BR0308305A - Fórmulas dosadas de liberação controlada - Google Patents
Fórmulas dosadas de liberação controladaInfo
- Publication number
- BR0308305A BR0308305A BR0308305-5A BR0308305A BR0308305A BR 0308305 A BR0308305 A BR 0308305A BR 0308305 A BR0308305 A BR 0308305A BR 0308305 A BR0308305 A BR 0308305A
- Authority
- BR
- Brazil
- Prior art keywords
- zero
- order
- controlled release
- metered
- dosed
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- 239000007787 solid Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36182102P | 2002-03-04 | 2002-03-04 | |
| US29161902A | 2002-11-12 | 2002-11-12 | |
| PCT/US2003/006591 WO2003075893A1 (en) | 2002-03-04 | 2003-03-03 | Controlled release dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0308305A true BR0308305A (pt) | 2004-12-28 |
Family
ID=27807664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0308305-5A BR0308305A (pt) | 2002-03-04 | 2003-03-03 | Fórmulas dosadas de liberação controlada |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1492508A4 (enExample) |
| JP (1) | JP2005524670A (enExample) |
| KR (1) | KR20100049695A (enExample) |
| CN (1) | CN1649569B (enExample) |
| AU (2) | AU2003217909C1 (enExample) |
| BR (1) | BR0308305A (enExample) |
| CA (1) | CA2477701A1 (enExample) |
| EA (1) | EA005866B1 (enExample) |
| IL (1) | IL163887A0 (enExample) |
| MX (1) | MXPA04008536A (enExample) |
| NO (1) | NO20044188L (enExample) |
| NZ (1) | NZ535083A (enExample) |
| WO (1) | WO2003075893A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| BR0312795A (pt) * | 2002-07-19 | 2005-05-10 | Ranbaxy Lab Ltd | Apresentação farmacêutica de sumatriptan, processo para sua preparação e método para tratar a enxaqueca |
| US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| CN1738600A (zh) * | 2002-11-12 | 2006-02-22 | 特瓦制药工业有限公司 | 用于口腔给药和舌下给药的替扎尼定药物组合物及剂型以及舌下或口腔给予替扎尼定的方法 |
| ES2618781T3 (es) * | 2003-11-14 | 2017-06-22 | Sanwa Kagaku Kenkyusho Co., Ltd. | Procedimiento de fabricación de un moldeado nucleado |
| GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
| GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
| CA2555406A1 (en) * | 2004-02-19 | 2005-09-01 | Teva Pharmaceutical Industries, Ltd. | Improved therapy using a combination of raloxifene and alendronate |
| KR100701409B1 (ko) | 2004-11-26 | 2007-03-30 | 한국유나이티드제약 주식회사 | 호박산 수마트립탄을 함유하는 약제학적 조성물 |
| AU2009281752B2 (en) | 2008-08-15 | 2016-11-17 | Depomed Inc. | Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders |
| CN110368371A (zh) * | 2014-04-08 | 2019-10-25 | 越洋医药开发(广州)有限公司 | 一种新型控释片 |
| JP6878417B2 (ja) * | 2016-02-17 | 2021-05-26 | トリアステック インコーポレイテッド | 剤形およびそれらの使用 |
| CN110604724A (zh) * | 2019-10-22 | 2019-12-24 | 恒诚制药集团淮南有限公司 | 一种肠溶美沙拉秦缓释片剂及其制备方法 |
| US20240122177A1 (en) * | 2022-10-13 | 2024-04-18 | Clarke Mosquito Control Products, Inc. | Insecticidal tablet compositions |
| JP2024083720A (ja) * | 2022-12-12 | 2024-06-24 | パナソニックＩｐマネジメント株式会社 | 水処理用徐放性固形薬剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB972128A (en) * | 1960-01-21 | 1964-10-07 | Wellcome Found | Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets |
| JPS61243016A (ja) * | 1985-04-19 | 1986-10-29 | Katsumi Takada | 柱状の有効成分含有部分をもつ錠剤 |
| GB8514666D0 (en) * | 1985-06-11 | 1985-07-10 | Coopers Animal Health | Agent delivery systems |
| JPS6253918A (ja) * | 1985-09-02 | 1987-03-09 | Katsumi Takada | 柱状の有効成分含有部分を埋没させた錠剤 |
| DE4431653C2 (de) * | 1994-09-06 | 2000-01-20 | Lohmann Therapie Syst Lts | Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
| JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
| CA2184316A1 (en) * | 1995-09-12 | 1997-03-13 | Wei-Chi Liao | Buccal delivery system for therapeutic agents |
| ATE214597T1 (de) * | 1997-12-19 | 2002-04-15 | Merck Patent Gmbh | Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien |
| PL192423B1 (pl) * | 1997-12-22 | 2006-10-31 | Schering Corp | Kompozycja farmaceutyczna typu molekularnej dyspersji |
| JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
| US6499984B1 (en) * | 2000-05-22 | 2002-12-31 | Warner-Lambert Company | Continuous production of pharmaceutical granulation |
| ATE417609T1 (de) * | 2000-06-28 | 2009-01-15 | Palmetto Pharmaceuticals Llc | Zusammensetzungen von arginin mit kontrollierter freigabe |
| WO2003057136A2 (en) * | 2001-12-24 | 2003-07-17 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
-
2003
- 2003-03-03 JP JP2003574168A patent/JP2005524670A/ja active Pending
- 2003-03-03 MX MXPA04008536A patent/MXPA04008536A/es active IP Right Grant
- 2003-03-03 WO PCT/US2003/006591 patent/WO2003075893A1/en not_active Ceased
- 2003-03-03 IL IL16388703A patent/IL163887A0/xx unknown
- 2003-03-03 EA EA200401097A patent/EA005866B1/ru not_active IP Right Cessation
- 2003-03-03 EP EP03713882A patent/EP1492508A4/en not_active Withdrawn
- 2003-03-03 KR KR1020107008536A patent/KR20100049695A/ko not_active Ceased
- 2003-03-03 CN CN038101068A patent/CN1649569B/zh not_active Expired - Fee Related
- 2003-03-03 BR BR0308305-5A patent/BR0308305A/pt not_active IP Right Cessation
- 2003-03-03 AU AU2003217909A patent/AU2003217909C1/en not_active Ceased
- 2003-03-03 NZ NZ535083A patent/NZ535083A/en not_active IP Right Cessation
- 2003-03-03 CA CA002477701A patent/CA2477701A1/en not_active Abandoned
-
2004
- 2004-10-01 NO NO20044188A patent/NO20044188L/no not_active Application Discontinuation
-
2009
- 2009-01-30 AU AU2009200353A patent/AU2009200353A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005524670A (ja) | 2005-08-18 |
| EA005866B1 (ru) | 2005-06-30 |
| EP1492508A1 (en) | 2005-01-05 |
| AU2003217909C1 (en) | 2009-06-11 |
| CN1649569A (zh) | 2005-08-03 |
| EA200401097A1 (ru) | 2005-04-28 |
| AU2003217909A1 (en) | 2003-09-22 |
| CN1649569B (zh) | 2010-05-05 |
| WO2003075893A1 (en) | 2003-09-18 |
| NZ535083A (en) | 2007-06-29 |
| AU2009200353A1 (en) | 2009-02-19 |
| IL163887A0 (en) | 2005-12-18 |
| MXPA04008536A (es) | 2005-09-08 |
| CA2477701A1 (en) | 2003-09-18 |
| NO20044188L (no) | 2004-12-03 |
| AU2003217909B2 (en) | 2008-10-30 |
| EP1492508A4 (en) | 2009-05-06 |
| KR20100049695A (ko) | 2010-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0215413A (pt) | Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção | |
| BR0308305A (pt) | Fórmulas dosadas de liberação controlada | |
| ES2217410T3 (es) | Forma de dosificacion oral de rapida desintegracion. | |
| JP4435424B2 (ja) | 口腔内で速やかに崩壊する錠剤 | |
| SE9804314D0 (sv) | New pharmaceutical formulation | |
| BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
| JP5336553B2 (ja) | 正確な用量分割機能を有する製剤 | |
| KR20120112644A (ko) | 록소프로펜 함유 의약 조성물 | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| IS7006A (is) | Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd | |
| NO20071044L (no) | Doseformer med enteraltbelagte tablettkjerner | |
| JP6009967B2 (ja) | 固形製剤 | |
| BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
| AP2003002763A0 (en) | Controlled release formulations for oral administration | |
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| JP7523879B2 (ja) | 医薬組成物 | |
| PE20030830A1 (es) | Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea | |
| BRPI0407438A (pt) | Sistema terapêutico compreendendo amoxicilina e ácido clavulânico | |
| TWI762450B (zh) | 超高速崩解錠劑及其製造方法 | |
| TWI731846B (zh) | 超高速崩解錠劑及其製造方法 | |
| JP2018100259A (ja) | 固形製剤 | |
| US20190350883A1 (en) | Pharmaceutical Composition of Acetaminophen/Ibuprofen | |
| US20080063709A1 (en) | Pharmaceutical compositions having novel scoring patterns | |
| JP2004331660A5 (enExample) | ||
| Saha | Immediate release drug delivery systems: a current update |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 31/195, 31/216, 31/4045, 31/433, 31/663, 45/06, 47/10, 47/16, 47/22, 47/26, 47/32, 47/34, 47/38, 9/20, 9/22, 9/24, 9/26; A61P 19/00, 25/00, 5/00, 9/00 Ipc: A61K 31/195 (2011.01), A61K 31/216 (2011.01), A61K |
|
| B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A, 10A E 11A ANUIDADES. |
|
| B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |